Detalhe da pesquisa
1.
Safety and tolerability of elbasvir/grazoprevir in chronic hepatitis C virus therapy: Integrated analysis from clinical trials.
J Viral Hepat
; 27(11): 1222-1233, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32594612
2.
Grazoprevir-Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection: A Randomized Trial.
Ann Intern Med
; 163(1): 1-13, 2015 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-25909356
3.
Safety and immunogenicity of the measles vector-based SARS-CoV-2 vaccine candidate, V591, in adults: results from a phase 1/2 randomised, double-blind, placebo-controlled, dose-ranging trial.
EBioMedicine
; 75: 103811, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35042081
4.
HIV seroconversion without infection after receipt of adenovirus-vectored HIV type 1 vaccine.
Clin Infect Dis
; 47(12): 1593-9, 2008 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18990058
5.
A Novel and Cost-Effective Method for Evaluating Cardiopulmonary Auscultation Skills in Student Physical Therapists.
J Allied Health
; 46(1): e9-e13, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28255599
6.
Long-term safety from the raltegravir clinical development program.
Curr HIV Res
; 9(1): 40-53, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21198432